Journal
/
면역학 및 감염병학
/
Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter
JoVE 신문
면역학 및 감염병학
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.  전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
JoVE 신문 면역학 및 감염병학
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Please note that all translations are automatically generated. Click here for the English version.

Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter

2,928 Views

•

07:44 min

•

August 12, 2021

DOI:

10.3791/62488-v

DOI:
10.3791/62488-v

•

07:44 min
August 12, 2021

•

1 Views
, , , , , , ,
1Ottawa Hospital Research Institute, 2Department of Biochemistry, Microbiology and Immunology,University of Ottawa, 3Department of Biotechnology,University of Tehran

Summary

Automatically generated

Das skizzierte Protokoll beschreibt das Verfahren zur Herstellung des HiBiT-Rezeptor-bindenden Domänenproteinkomplexes und seine Anwendung für den schnellen und sensitiven Nachweis von SARS-CoV-2-Antikörpern.

Explore More Videos

SARS-CoV-2Receptor-binding DomainAntibody DetectionHiBiT-based BioreporterCOVID-19 ResearchHigh-throughput AssayCell CultureTransfectionPassive Lysis Buffer

Read Article

Cite this Article

Rezaei, R., Surendran, A., Singaravelu, R., Jamieson, T. R., Taklifi, P., Poutou, J., Azad, T., Ilkow, C. S. Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter. J. Vis. Exp. (174), e62488, doi:10.3791/62488 (2021).

Download .ris file

Copy

Share Video

.

Copy